A new bandage treatment, known as a scaffold, to treat diabetic foot ulcers. This treatment is cost-effective while improving patient outcomes. It has been designed by researchers at Queen's University Belfast. Produced by 3D bioprinting, the scaffolds slowly release antibiotics over a four-week period to effectively treat the wound. This new research demonstrates outcomes with significant implications for patient quality of life. It also decreases the costs and clinical burden in treating DFU. Professor Dimitrios Lamprou, Advanced Manufacturing at Queen's School of Pharmacy and corresponding author, explains: "These scaffolds are like windows that enable doctors to monitor the healing constantly. This avoids needing to remove them constantly, which can provoke infection and delay the healing process. Lead author Ms Katie Glover, from the Queen's School of Pharmacy, concludes: "Using bioprinting technology, we have developed a scaffold with suitable mechanical properties to treat the wound, which can be easily modified to the size of the wound."